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Adult polycystic kidney disease: Studies of the defect in urine
concentration. Patients with adult polycystic kidney disease with
and without renal insufficiency and some of their family members
in whom cysts were not demonstrable by radiography underwent
tests of maximal urine concentrating ability (Umax). Ten of the
twelve family members without demonstrable cysts (Group I)
had Umax exceeding 900 mOsm/kg. Eleven of the 13 subjects
with polycystic kidneys but without renal insufficiency (Group II)
had Umax below 700 mOsm/kg after 24 hours of dehydration and
excess exogenous vasopressin. Patients with polycystic kidney
and renal insufficiency (Group III) excreted urines of osmolalities
which were only slightly higher than that of plasma after de-
hydration and vasopressin. The nature of the defect in Umax was
further characterized by examining the capacity to maximally
concentrate the urine (T,0) during conditions of increasing
osmolar clearance (Cosm) and the capacity to maximally dilute
the urine (CH2O) in the presence of increased delivery of sodium
to the diluting site. Group II patients had varying inabilities to
maximally concentrate the urine, while this function was uni-
formly abnormal in all patients in Group III. Nevertheless, all
patients were able to elaborate a maximally dilute urine and to
increase CH2O with increasing distal delivery. It is concluded
that the defect in Umax is not the result of diminished glomerular
filtration rate nor a defect in sodium reabsorption in the ascending
limb of Henle's loop. This defect, which is aggravated by increased
osmotic load per nephron in Group III patients, may result
from alterations in collecting duct function or medullary archi-
tecture due to the presence of cysts.
Polykystose rénale de l'adulte: Demonstration d'un défaut de
concentration. Des malades adultes atteints de polykystose rénale
avec et sans insuffisance rénale et quelques membres de leurs
families chez lesquels des kystes n'étaient pas mis en evidence
par Ia radiographie ont subi des épreuves de concentration
urinaire maximale (Umax). Dix des douze membres d'une
famille sans kystes démontrables (groupe I) avaient un Umax
dépassant 900 mOsm/kg. Onze des treize sujets ayant des reins
polykystiques sans insuffisance rénale (groupe II) avaient un
Umax inférieur a 700 mOsm/kg aprés 24 heures de deshydrata-
tion et sous excès de vasopressine exogène. Les malades ayant
des reins polykystiques et une insuffisance rénale (groupe III)
excrétaient des urines dont l'osmolalité était a peine supérieure
a celle du plasma aprés deshydratation et vasopressine. La nature
du deficit de Umax a été caractérisée par l'Ctude de Ia capacité
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maximale de concentrer l'urine dans des conditions de clearance
osmolaire (Cosm) augmentée et de Ia capacité maximale de
diluer l'urine (CH2O) en presence d'une augmentation du debit
de sodium au segment de dilution. Les malades du groupe II
avaient un deficit variable de Ia concentration maximale de
l'urine alors que cette fonction était uniformément altérée chez
tous les malades du groupe III. Cependant tous les malades
Ctaient capables d'élaborer une urine diluée au maximum et
d'augmenter le debit d'eau libre en fonction de l'augmentation
du debit distal. Il est conclu que le deficit de Umax est Ic rCsultat
d'altérations de Ia perméabilité a l'eau du canal collecteur qui,
chez les malades du groupe III est combinée a une augmentation
de Ia charge osmotique par néphron.
The diagnosis of adult polycystic kidney disease usually
rests on the radiological demonstration of the cysts [1, 2].
A family history is almost always obtained which suggests
autosomal dominant transmission [3]. Renal function may
be normal or impaired at the time the presence of the disease
is established. The magnitude of the functional impairment
often does not correlate with the degree of involvement
suggested by urography [3]. Nevertheless, renal insufficiency
is the result of increasing size and/or number of cysts
which eventually replace normal kidney tissue [3—5]. In
addition, renal function may be worsened by the develop-
ment of hypertension, infection and/or obstruction, all
of which may be complications of the disease [3—5]. Thus,
it would be desirable to determine which members of the
family of patients with polycystic kidneys harbor the dis-
ease, since early identification may allow for closer follow-
up of renal function and treatment of complications.
Inability to concentrate the urine is a common finding
in patients with chronic renal failure [6] and its occurrence
when polycystic kidney disease is advanced- is not un-
expected. Because a major site of cyst formation seems
to be the collecting duct, principally at the corticomedullary
junction [4, 7] and, since cystic nephrons contribute to the
final composition of the urine [8, 9], one might expect
that derangements in urine concentration would constitute
an early functional abnormality in patients with cysts
but well maintained renal function.
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In the present studies the urine concentrating ability of
family members of patients with advanced polycystic
kidney disease has been examined. Inability to maximally
concentrate the urine was found in most family members
with radiologically demonstrated cysts, despite otherwise
well-preserved renal function. To characterize the nature
of this abnormality, the functional state of the distal
nephron (ascending limb of Henle's loop) was studied in
some patients by determination of the capacity to con-
centrate and dilute the urine under conditions of enhanced
sodium delivery to that site. Normally, increased distal
delivery of sodium during hydropenia results in increased
solute-free water reabsorption (T20) and, during water
diuresis, in increased solute-free water clearance (CH20).
Both T20 and CH20 are indirect indices of sodium re-
absorption in the loop of Henle and expressions of its
functional integrity.
Methods
A total of 33 subjects was studied. Group I (Table 1)
consisted of 12 family members without demonstrable
cysts. The diagnosis of polycystic kidneys was based on a
positive family history, drip (prolonged) infusion intra-
venous pyelograms with tomography and, in some in-
stances, renal arteriograms. Group II (Table 2) consisted
of 13 patients with polycystic kidneys without renal in-
sufficiency (GFR >60 mI/mm). Group III (Table 3) con-
sisted of eight patients with polycystic kidneys whose GFR
was 10 mI/mm or less1. Patients in Group III were stable
at the time of study and did not have manifestations of the
uremic syndrome. All patients were admitted to the Baylor
Clinical Research Center (CRC) for study after their in-
formed consent had been obtained. Laboratory studies
included hemograms, blood urea nitrogen, serum creatinine,
sodium, potassium, chloride, bicarbonate, calcium, phos-
phate and uric acid; urinalysis, urine cultures, 24-hour
protein excretion and creatinine clearance were also per-
formed. Hemoglobin electrophoresis was done on all black
patients.
Patients without renal insufficiency were studied four
to five days after admission to the CRC while on a diet
containing at least 100 mEq of sodium per day and water
ad libitum. Patients with a GFR of less than 10 mI/mm
were given diets containing 30 g high biological value
proteins. Dietary sodium intake had to be individualized
for each of these patients (40 to 100 mEq) but studies were
not performed until the time when sodium intake equaled
urinary output and weight, blood urea nitrogen and serum
creatinine had remained constant for at least three days.
1 For simplicity, the terms with and without renal insufficiency
are used in the text to describe patients in Groups III and II,
respectively. The grouping, however, has been done utilizing
the criteria for the evaluation of the severity of established
renal disease of the Council on the Kidney in Cardiovascular
Disease, American Heart Association, 1971 (Ann Intern Med
75:251—252, 1971).
Diastolic blood pressure did not exceed 110mm Hg in
any of the subjects studied and none had evidence of con-
gestive heart failure.
Maximal urine concentrating ability (Umax). Patients were
deprived of water for 16 hours. At the end of this period,
urine and serum osmolality were measured and five units
of vasopressin tannate in oil given subcutaneously. Urine
and serum osmolality were repeated at the end of 20 and
24 hours from the beginning of water deprivation and the
highest urine osmolality attained taken as Umax.
Urine concentrating capacity (T20). Eight patients in
Group I, eight in Group II and four in Group ill were
studied. At the end of the determination of Umax, priming
doses of '251-iothalamate or inulin were given, followed
by the infusion of isotonic saline at a rate of 1 mI/mm
calculated to deliver appropriate maintenance doses of the
glomerular marker and aqueous vasopressin, 200 milli-
units/hr. After a 45-minute equilibration period, 3%
sodium chloride solution was administered by a constant
infusion pump at rates of 5 to 7 mI/mm initially, and then
at increasing rates until a total of 1,500 ml was given.
In patients with renal insufficiency, a total of only 500 ml
was given.
Urine diluting capacity (CH2O). Studies were performed
on all subjects in whom T20 was measured except three
patients in Group II. Subjects were deprived of food but
not water for 12 hours before the study. Water diuresis
was induced by the oral administration of water, 20 mI/kg
of body wt. Every 30 mm the subjects drank an amount
of water equal to the urine flow plus 1.0 ml/min to replace
insensible losses. This procedure uniformly led to urine
osmolalities below 100 mOsm/kg. When urine flow and
osmolality were constant on two consecutive specimens,
1251-iothalamate or inulin were given as described above.
After the equilibration period, 0.45% saline was infused
at increasing rates ranging from 4 to 16 mI/mm.
Blood and urine specimens were collected at intervals
of 15 to 30 mm from a Cournand needle in the brachial
artery and an indwelling bladder catheter, respectively,
and analyzed for sodium, potassium, osmolality and inulin
or 1251-iothalamate. The analytical methods for these
procedures have been previously described from this
laboratory [10]. T20 and CH20 were calculated by standard
formulae.
Results
Pertinent clinical and laboratory information for each
group is summarized in Tables 1 to 3. Group I (Table 1)
consisted of seven women and five men 12 to 54 years old.
GFR was 90 mI/mm or greater in all. Umax exceeded
970 mOsm/kg (mean: 1060± 134) in all subjects except
two (AC and LC), in one of whom (AC) the dehydration
test was discontinued after 12 hrs at his request.
Group 11 (Table 2) consisted of five men and eight women
with ages ranging from 16 to 49 years. Glomerular filtra-
tion rate was 77 mI/mm or greater in all but one patient
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Table 1. Group I: Family members without cysts
Serum Glomerular
Patient Age Sex Urea
nitrogen
mg/100ml
Crea-
tinine
mg/100 ml
filtration
ratea
mi/mm
Umax
mOsm/kg
BM 18 F 14 0.9 90 1191
BH 24 F 16 1.0 152 1023
AC 14 M 12 0.9 162 810
CE 21 F 14 1.0 — 1200
ALS 25 M 22 1.0 174b 1140
BLH 14 F 12 1.0 100 1050
LC 54 F 14 0.9 130b 840
JL 15 M 11 1.3 120 1162
HL 23 M 15 1.5 110 1092
MAC 14 F 11 1.2 — 972
EC 12 F 11 1.2 — 1209
BE 38 M 12 1.3 100 1032
a Corrected to 1.73 m2 BSA; values represent creatinine clearance
b Inulin clearance
(FM), in whom it was 60 mI/mm. Serum calcium and uric
acid were normal in all subjects in whom these were
measured, except for one (LS) who had hyperuricemia.
Umax ranged from 446 to 936 mOsm/kg with a mcan of
657 169 mOsm/kg. This value was significantly different
from that obtained for Group I (P <0.001). Three of the
patients (KH, FM and AL) had mild hypertension. All
patients had negative urine cultures and were free from
symptoms of urinary tract infection at the time of study,
but two patients (LG and MV) gave a history of "cystitis"
shortly after marriage two and three years prior to study.
One patient had had one episode of hematuria (BB);
another (OM) has a small intrarenal calculus. Two patients
(RH and SH) who are siblings have sickle hemoglobin.
Group III (Table 3) consisted of eight men2 whose age
ranged from 40 to 75 years. As expected, serum uric acid
tended to be high and calcium tended to be low in some
of the patients. Hypokalemia was not present in any
member of this group or any of the other two groups. Umax
did not exceed 340 mOsm/kg in any of the patients; these
values were only slightly hypertonic to plasma, in one
patient (AE, Table 3) in whom sickle cell trait coexists
with polycystic kidney disease, urine osmolality did not
exceed 192 mOsm/kg after 24 hours dehydration and
vasopressin. Patient MM was mildly hypertensive. Urine
cultures were negative at the time of study and for the six
months prior to study, and the subjects had been free
of any symptoms of urinary tract infection for at least
one year.
Free water reabsorption (Ti120) The results of the infusion
of 3 % saline to Group I patients are depicted in Fig. 1.
In all patients T20 rose with increasing Cøsm resulting
in a curve, the limits of which are given by the shaded area.
Patients in Group II exhibited four different patterns
in the relationship of T20 to Cosm. In two patients (MC
and AS) whose Umax was over 900 mOsmJkg, T20 rose
throughout the range of Cosm examined (Fig. 2a) and fell
within the limits of the normal curve. On the other hand,
T20 did not rise any further as Cosm/GFR x 100 increased
from 12 to 16 in patients LG, DG and OM (Fig. 2b). These
patients were in the lower limits of normal of the T20/
Cøsm curve. A fall in T20 as C0sm/GFR x 100 increased
from 12 to 16 was observed in HK (Fig. 2c). The curve
describing the relationship between T20 and Csm was
2 The preponderance of males in this group reflects the fact that
all of these patients were seen at the Veterans Administration
Hospital.
Table 2. Group II: Polycystic kidneys without renal insufficiency (Classes I, A to B, l)a
Patient Age Sex
Serum Glomerular
filtration
rateb Umax
Medical
complications•Urea
nitrogen
Creatinine Calcium Uric acid
mg/100 ml mg/100 ml mg/100ml mg/100 ml ml/min mOsm/kg
FM 39 M 30 2.0 9.4 7.0 60 449 Modest hypertension (140/90)
AL 39 F 20 1.1 — — 77 650 Modest hypertension (130/90)
L5 49 M 26 1.9 9.6 6.3 82 589 None
OM 38 F 26 1.0 9.6 4.2 90 569 Intrarenal stone (1 x 3 mm)
BB 41 M 26 1.4 10.0 5.2 97 632 One episode of gross hematuria
(1 mo before study)
MV 20 F 14 0.8 — 4.6 100 930 Cystitis (no sequelae)
DG 26 F 16 1.0 10.1 6.6 102 446 None
HK 44 M 25 1.2 10.0 5.6 109 551 Modest hypertension (140/90)
LG 20 F 16 1.0 9.4 4.6 117 669 Cystitis (no sequelae)
MC 16 F 15 0.6 9.4 4.0 143C 801 None
AS 21 M 22 1.1 — l65 936 None
RHd 40 F 21 1.5 10.0 4.8 97 446 SA trait
SHe 20 F 16 0.9 — — 100 514 SS disease
a Classification according to the Council on the Kidney in Cardiovascular Disease, American Heart Association.
"Corrected to 1.73 m2 BSA; values represent creatinine clearance
o Inulin clearance
d Not included in statistical analysis
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Table 3. Group III: Polycystic kidneys with renal insufficiency (Classes II—IV, D to F, 2 to 3)
Patient Age Sex
Serum Glomerular
Filtration
Rateb
UmaxUrea
Nitrogen
.Creatinine Calcium •Uric Acid
mg/100 ml mg/100 ml mg/100 ml mg/100 ml mi/mm mOsm/kg
AE 42 M 100 15.7 6.2 8.9 5.0 192
RP 43 M 92 11.2 9.0 8.3 5.0 340
MM 50 M 92 13.2 9.5 8.2 6.0 321
LH 40 M 110 14.7 8.6 12.0 6.0 320
JK 75 M 69 6.2 8.9 6.8 8.0 300
HG 57 M 92 12.3 9.0 11.3 9.0 316
NS 52 M 46 8.1 10.2 7.8 10.0 310
WG 49 M 97 7.2 7.0 6.8 10.0 294
a Classification according to the Council on the Kidney in Cardiovascular Disease, American Heart Association.
b These values were not corrected for BSA.
lower in RH than in all other patients except FM, in
whom T20 did not change appreciably as Csm rose from
about 7 to 19% of the filtered load (Fig. 2d). Both curves
were drastically abnormal.
The relationship between Cosm and T320 in Group III
is depicted in Fig. 3. It is apparent that hypertonic saline
infusion did not result in marked rises in T20 in these
patients with GFR less than 10 mi/mm, despite significant
increases in Cosm. Only in one patient (HG) was the rise
in Cosm accompanied by transient elevations in Ti2O. In
all other patients T,0 became negative; in other words,
solute-free water excretion rather than reabsorption. The
beginning high rate of Cosm is undoubtedly the result of an
existing osmotic diuresis before commencing the experi-
rnent.
Free water clearance (CH2O). Fig. 4 illustrates the rela-
tionship between CH20 and urine flow (V) in Group I
and Group II patients. The limits of the stippled area
represent the normal CH20-to-V relationship obtained in
Osmolar clearance (Cosm)/GFR x 100
Fig. 1. Relationship between fractional free waler reabsorption
and osmolar clearance in normal patients (Group I).
Group I patients. To examine the spectrum of the func-
tional status of patients in whom T20 was examined, we
studied one whose curve is in the lower limits of normal
(OM) and one who had a normal T20 curve (AS). In
addition, both patients whose T2O/COSm curve was ab-
normal (Fig. 2 d) were studied. It is clear that there is no
difference between these and the values obtained in patients
from Group I. In both groups, CH20 rose with increasing
rates of V without evidence of a limit being reached. Free
water clearance also rose with increasing V in Group III
patients (Fig. 5). Since the range of V and C20 in this group
is different from that in Groups I and II, they are not
directly comparable. Nevertheless, the ratio CH20/V is
similar between the two groups in the range where CH2O
rises with increasing V (30 to 50% of filtered load), indicat-
ing that the relationship is not different among the groups.
Discussion
The present studies demonstrate that, as in the case
of other renal diseases, patients with polycystic kidneys
and some impairment of renal function have diminished
Umax with a preserved capacity to dilute the urine [11, 12].
More importantly, however, the renal response to de-
hydration was also abnormal in 8 out of the 10 patients
in Group 11 whose GFR was over 75 mI/mm (Table 2).
Of the other three patients who failed to concentrate,
two had S-hemoglobin and one had a GFR of 60 ml/min.
In patients with polycystic kidney disease and renal in-
sufficiency (Group III), urine osmolality after 24 hr de-
hydration was only slightly above plasma in eight patients
and frankly hypotonic in one (AE, Table 3). These findings
indicate that the response to endogenous antidiuretic hor-
mone (ADH) was abnormal. Furthermore, the exogenous ad-
ministration of vasopressin did not appreciably alter Umax,
indicating that the renal response to the hormone is altered.
The possibility that ADH release is deranged in patients
with polycystic kidney does not appear to be very likely.
Umax values were clearly above plasma in all patients in
Group II and patients AS, MC and MV were able to
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Fig. 2. Relationship between fractional free
water reabsorption and osmolar clearance
in Group II patients. The striped curve is
that shown in Fig. 1. Each symbol repre-
sents a different patient (see text). Osmolar clearance (C0)/G FR x 100
excrete urine with concentrations above 800 mOsm/kg
in response to dehydration.
It is possible that the diminished Umax and the apparent
unresponsiveness of the distal nephron to endogenous
and exogenous ADFI is a manifestation of a reduced
medullary and papillary interstitial osmolality resulting
from dininished sodium transport by the loop of Henle
leading, in turn, to diminished water reabsorption from
the collecting duct. To assess the capacity for sodium
transport in the loop, T20 was measured as a function
of Cosm during hypertonic saline diuresis. Group II patients
who had abnormal Umax followed three major patterns
in their response to saline infusion. Three patients had the
capacity to reabsorb solute-free water but its relationship
to Cosm was at the lower limit of normal; in another
patient T20 initially followed a similar pattern but
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Fig. 3. Relationship between fractional free water reabsorption
and osmolar clearance in Group III patients.
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eventually fell below the normal range; and 3 patients had
a clearly abnormal relationship of T20 to C0sm (Fig. 2).
In addition, all patients in Group III had abnormal T/
Cosm relationship. These findings suggest alterations in
the transport characteristics of the distal nephron. The
results obtained during infusions of hypotonic saline, how-
ever, make it unlikely that impairment in the intrinsic
ability of the ascending limb to reabsorb sodium is the
mechanism for the concentrating defect. All groups
responded to the increased delivery of sodium to the distal
nephron with a normal increase in the excretion of solute-
free water as urine flow rose. All evidence indicates, there-
fore, that the defect in Umax, and in T20 when present,
is not the result of inability to reabsorb sodium normally
in the ascending limb of Henle's loop.
Changes in GFR leading to diminished sodium delivery
to the loop of Henle might account for the diminished Umax
in those patients in Group II (FM and AL) in whom it was
low [13]. This would not explain, however, the low T20
when sodium delivery was enhanced by hypertonic saline
infusion.
From the response to hypertonic saline infusion in
Group III it may be deduced that osmotic diuresis in the
remaining nephrons is in part responsible for the inability
to maximally concentrate the urine in this group [14, 15].
In most of the patients the urine actually became dilute
despite the resulting rise in blood osmolality and in osmo-
lar clearance, suggesting that "disequilibrium", the entry
of large volumes of dilute tubular fluid into collecting
ducts which do not equilibrate with the hypertonic inter-
stitium [16], occurred. The abnormality in Umax in this
group, therefore, may be in part the result of the con-
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tinuous osmotic diuresis. Patients in Group II responded
to the infusion of hypertonic saline by a rise in free water
reabsorption as osmolar clearance rose without the urine
becoming dilute. Since these patients also had cysts, it is
clear that the distal "disequilibrium" observed in Group 111
patients was not a simple function of their presence but,
rather, the manifestation of the superimposition of an
osmotic load on residual nephrons already undergoing
osmotic diuresis. On the other hand, since cysts alone, in the
absence of azotemia, can lead to diminished Umax, osmotic
diuresis in the remaining nephrons cannot alone explain the
defect in Group Ill.
Other causes of abnormal Umax, such as hypercalcemia
[17], hypokalemia [18] and hyperuricemia [19] were not
present in our patients. Bacteriuria, which has been
associated with a diminished Umax [20, 211, conceivably
might have contributed in patients MV and LG (Group II),
but the history in these two patients makes it highly un-
likely. Abnormalities in Umax have also been described
in patients with hypertension. Three of the patients in
Fig. 4. Relationship between fractional free
water clearance and fractional urine flow.
The stippled curve represents the normal
range obtained in Group I patients. Each
22 symbol represents a patient from Group II
(see text).
Group II were mildly hypertensive. Nevertheless, none
of these patients had diminished capacity to dilute his
urine, a defect which characterizes the loop effects of hyper-
tension [22]. Two patients in Group 11 and one in Group III
have sickle hemoglobin, a condition which also leads to
abnormal Umax [23, 24]. In these patients, particularly
in AE who constantly excreted a dilute urine, the abnormal
hemoglobin must have aggravated the impairment in Umax.
The abnormal renal response to ADH in patients with
polycystic kidneys may be due to structural abnormalities
of the collecting ducts. Histological studies have revealed
that dilatation, interstitial fibrosis and/or thickening of the
basement membrane of the collecting duct are common
histological findings in adult polycystic kidney disease
[3, 4, 7, 25]. These alterations may render these structures
relatively unresponsive to ADH. On the other hand,
the architectural disruption of medullary structures could
lead to a circumstance where, despite the occurrence of
normal ADH-induced permeability changes, effective
diffusion of water cannot proceed [26].
It is evident that, when present in patients with well
preserved renal function, the changes in Umax and T20
may represent the consequence of primarily medullary
or corticomedullary involvement with cysts. Similar changes
are found in other diseases which affect the renal medulla
predominantly without necessarily reducing GFR, such as
pyelonephritis [20, 21] and sickle hemoglobin [23, 24].
Therefore, the changes in Umax and T20 are not specific
for polycystic kidney disease but the expression of a specific
anatomical involvement. On the other hand, the defect
in urine concentration in both sickle hemoglobin and
pyelonephritis is reversible early in the disease and appears
to be primarily due to hemodynamic alterations, while
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Fig. 5. Relationship between fractional free water clearance and
fractional nrine flow in Group III patients.
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that in polycystic kidneys is principally structural and
irreversible. All cysts do not arise in the corticomedullary
junction or from the collecting duct, so that the finding
of some patients in Group II with radiologically proven
cysts and normal Umax was not surprising. In fact, one
would expect that if the great majority of cysts are elsewhere
(cortical structures) a Umax defect will not be found.
On the other hand, the somewhat low Umax in patient LC
(Group I) makes her suspect of harboring cysts in her
medulla which are radiologically undetectable. It is of
interest in this context that, in an experimental model of
polycystic kidney disease which resembles the adult form,
diminished Umax is present at a time when cysts are not
histologically demonstrable [27, 281. These observations
offer an alternative and attractive possibility for the Umax
abnormality in polycystic kidney disease. The basis for this
functional derangement and, eventually, for cyst formation
and other structural changes might be an inherited cellular
metabolic disorder.
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